Optic Nerve Head Structural Response to IOP Elevation in Patients With Keratoconus
Sponsor: NYU Langone Health
Terminated
This study was terminated due to the departure of the Principal Investigator from the Sponsoring institution.
Other terminated trials from NYU Langone Health
Other Glaucoma trials with similar outcome
Listed as NCT03560609, this NA trial focuses on Glaucoma and Keratoconus and remains terminated or withdrawn. Sponsored by NYU Langone Health, it has been updated 15 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Feb 2025 — Present [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
-
Dec 2022 — Nov 2023 [monthly]
Recruiting NA
▶ Show 10 earlier versions
-
May 2022 — Dec 2022 [monthly]
Recruiting NA
-
Jun 2021 — May 2022 [monthly]
Recruiting NA
-
Jan 2021 — Jun 2021 [monthly]
Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2020 — Jun 2020 [monthly]
Not Yet Recruiting NA
-
Jun 2019 — Feb 2020 [monthly]
Not Yet Recruiting NA
-
May 2019 — Jun 2019 [monthly]
Not Yet Recruiting NA
-
Feb 2019 — May 2019 [monthly]
Not Yet Recruiting NA
Phase: PHASE3 → NA
-
Nov 2018 — Feb 2019 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- NYU Langone Health
- National Eye Institute (NEI)
For direct contact, visit the study record on ClinicalTrials.gov .